Patent
 (2020)

c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same

Southall, Noel; Dulcey, Andres; Marugan, Juan; Talley, Daniel; Ferrer, Marc; Alvarez, Alejandra B; Von Bernhardi, Rommy E.; Zanlungo, Silvana.

Más información

Fecha de publicación: 2020
DOI:

202002317
Notas: Published patent WO2019173761A1 “c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same". -PCT national phase in the USA, entered on August 26, 2020, under N ° 16 / 976,012 -National phase PCT in Chile, entered on September 7, 2020, under the N ° 20200231